奥马珠单抗对慢性特发性/自发性荨麻疹患者血液嗜碱性粒细胞计数的影响。 - Suppr

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.

作者信息

Saini Sarbjit S, Omachi Theodore A, Trzaskoma Benjamin, Hulter Henry N, Rosén Karin, Sterba Patricia M, Courneya Jean-Paul, Lackey Alan, Chen Hubert

机构信息

Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.

Genentech, Inc., South San Francisco, California, USA.

出版信息

J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.

DOI:10.1016/j.jid.2016.11.025

PMID:27939380

Abstract

摘要

相似文献

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.

J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.

Basophil FcɛRI expression is linked to time to omalizumab response in chronic spontaneous urticaria.

J Allergy Clin Immunol. 2018 Jun;141(6):2313-2316.e1. doi: 10.1016/j.jaci.2018.02.021. Epub 2018 Mar 5.

Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.

Clin Exp Allergy. 2018 Feb;48(2):196-204. doi: 10.1111/cea.13066. Epub 2017 Dec 12.

Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.

Acta Derm Venereol. 2017 Jun 9;97(6):698-704. doi: 10.2340/00015555-2654.

[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].

Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4.

Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.

Clin Exp Allergy. 2021 Dec;51(12):1648-1652. doi: 10.1111/cea.14014. Epub 2021 Sep 20.

The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders.

Clin Exp Allergy. 2018 Jul;48(7):898-901. doi: 10.1111/cea.13149. Epub 2018 May 20.

Basophil count is a sensitive marker for clinical progression in a chronic spontaneous urticaria patient treated with omalizumab.

Allergol Int. 2019 Jul;68(3):388-390. doi: 10.1016/j.alit.2019.02.002. Epub 2019 Feb 18.

A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria.

Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.

引用本文的文献

Chronic Spontaneous Urticaria: Etiology and Pathogenesis.

Immunol Allergy Clin North Am. 2024 Aug;44(3):421-438. doi: 10.1016/j.iac.2024.03.002. Epub 2024 May 18.

Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study.

J Allergy Clin Immunol Glob. 2024 Mar 19;3(2):100245. doi: 10.1016/j.jacig.2024.100245. eCollection 2024 May.

Research progress in the pathogenesis of chronic urticaria.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1602-1610. doi: 10.11817/j.issn.1672-7347.2023.230037.

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation.

Biomedicines. 2023 May 25;11(6):1537. doi: 10.3390/biomedicines11061537.

Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment.

Clin Cosmet Investig Dermatol. 2023 Feb 4;16:345-357. doi: 10.2147/CCID.S393406. eCollection 2023.

Skin-homing basophils and beyond.

Front Immunol. 2022 Dec 22;13:1059098. doi: 10.3389/fimmu.2022.1059098. eCollection 2022.

Basophils from allergy to cancer.

Front Immunol. 2022 Dec 12;13:1056838. doi: 10.3389/fimmu.2022.1056838. eCollection 2022.

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship.

Front Allergy. 2022 Nov 17;3:1008145. doi: 10.3389/falgy.2022.1008145. eCollection 2022.

Decreased peripheral basophil counts in urticaria and mouse model of oxazolone-induced hypersensitivity, the latter suggesting basopenia reflecting migration to skin.

Front Immunol. 2022 Sep 29;13:1014924. doi: 10.3389/fimmu.2022.1014924. eCollection 2022.

Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease.

J Clin Med. 2022 Jul 30;11(15):4453. doi: 10.3390/jcm11154453.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.

J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.

Basophil FcɛRI expression is linked to time to omalizumab response in chronic spontaneous urticaria.

J Allergy Clin Immunol. 2018 Jun;141(6):2313-2316.e1. doi: 10.1016/j.jaci.2018.02.021. Epub 2018 Mar 5.

Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.

Clin Exp Allergy. 2018 Feb;48(2):196-204. doi: 10.1111/cea.13066. Epub 2017 Dec 12.

Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.

Acta Derm Venereol. 2017 Jun 9;97(6):698-704. doi: 10.2340/00015555-2654.

[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].

Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4.

Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.

Clin Exp Allergy. 2021 Dec;51(12):1648-1652. doi: 10.1111/cea.14014. Epub 2021 Sep 20.

The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders.

Clin Exp Allergy. 2018 Jul;48(7):898-901. doi: 10.1111/cea.13149. Epub 2018 May 20.

Basophil count is a sensitive marker for clinical progression in a chronic spontaneous urticaria patient treated with omalizumab.

Allergol Int. 2019 Jul;68(3):388-390. doi: 10.1016/j.alit.2019.02.002. Epub 2019 Feb 18.

A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria.

Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.

引用本文的文献

Chronic Spontaneous Urticaria: Etiology and Pathogenesis.

Immunol Allergy Clin North Am. 2024 Aug;44(3):421-438. doi: 10.1016/j.iac.2024.03.002. Epub 2024 May 18.

Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study.

J Allergy Clin Immunol Glob. 2024 Mar 19;3(2):100245. doi: 10.1016/j.jacig.2024.100245. eCollection 2024 May.

Research progress in the pathogenesis of chronic urticaria.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1602-1610. doi: 10.11817/j.issn.1672-7347.2023.230037.

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation.

Biomedicines. 2023 May 25;11(6):1537. doi: 10.3390/biomedicines11061537.

Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment.

Clin Cosmet Investig Dermatol. 2023 Feb 4;16:345-357. doi: 10.2147/CCID.S393406. eCollection 2023.

Skin-homing basophils and beyond.

Front Immunol. 2022 Dec 22;13:1059098. doi: 10.3389/fimmu.2022.1059098. eCollection 2022.

Basophils from allergy to cancer.

Front Immunol. 2022 Dec 12;13:1056838. doi: 10.3389/fimmu.2022.1056838. eCollection 2022.

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship.

Front Allergy. 2022 Nov 17;3:1008145. doi: 10.3389/falgy.2022.1008145. eCollection 2022.

Decreased peripheral basophil counts in urticaria and mouse model of oxazolone-induced hypersensitivity, the latter suggesting basopenia reflecting migration to skin.

Front Immunol. 2022 Sep 29;13:1014924. doi: 10.3389/fimmu.2022.1014924. eCollection 2022.

Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease.

J Clin Med. 2022 Jul 30;11(15):4453. doi: 10.3390/jcm11154453.

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.

作者信息

Saini Sarbjit S, Omachi Theodore A, Trzaskoma Benjamin, Hulter Henry N, Rosén Karin, Sterba Patricia M, Courneya Jean-Paul, Lackey Alan, Chen Hubert

机构信息

Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.

Genentech, Inc., South San Francisco, California, USA.

出版信息

J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.

DOI:10.1016/j.jid.2016.11.025

PMID:27939380

Abstract

摘要

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.

作者信息

机构信息

出版信息